Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (3-(2-methyl-5-nitroimidazol-1-yl)-propan-1-ol)
2. 3-(2-methyl-5-nitroimidazol-1-yl)-propan-1-ol
1. 1077-93-6
2. Ternidazole [inn]
3. 3-(2-methyl-5-nitroimidazol-1-yl)propan-1-ol
4. 4n8r018qb0
5. 3-(2-methyl-5-nitro-1h-imidazol-1-yl)propan-1-ol
6. Ternidazol
7. Ternidazolum
8. Ternidazol [inn-spanish]
9. Ternidazolum [inn-latin]
10. 1-(3-hydroxypropyl)-2-methyl-5-nitro-1h-imidazole
11. Unii-4n8r018qb0
12. Einecs 214-077-5
13. 1h-imidazole-1-propanol, 2-methyl-5-nitro-
14. Ternidazole [mart.]
15. Ternidazole [who-dd]
16. Chembl185647
17. Schembl2108944
18. Dtxsid60862525
19. Zinc1846040
20. 2-methyl-5-nitroimidazole-1-propanol
21. Akos006271736
22. Am90173
23. Ft-0691786
24. 1-(3-hydroxypropyl)-2-methyl-5-nitroimidazole
25. 077t936
26. 3-(2-methyl-5-nitroimidazol-1-yl)-propan-1-ol
27. (3-(2-methyl-5-nitroimidazol-1-yl)-propan-1-ol)
28. Q27260224
Molecular Weight | 185.18 g/mol |
---|---|
Molecular Formula | C7H11N3O3 |
XLogP3 | -1.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 185.08004122 g/mol |
Monoisotopic Mass | 185.08004122 g/mol |
Topological Polar Surface Area | 83.9 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 182 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Date of Issue : 2019-07-22
Valid Till : 2022-07-02
Written Confirmation Number : WC-0135
Address of the Firm :
Market Place
ABOUT THIS PAGE
68
PharmaCompass offers a list of Ternidazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ternidazole manufacturer or Ternidazole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ternidazole manufacturer or Ternidazole supplier.
PharmaCompass also assists you with knowing the Ternidazole API Price utilized in the formulation of products. Ternidazole API Price is not always fixed or binding as the Ternidazole Price is obtained through a variety of data sources. The Ternidazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ternidazol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ternidazol, including repackagers and relabelers. The FDA regulates Ternidazol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ternidazol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ternidazol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ternidazol supplier is an individual or a company that provides Ternidazol active pharmaceutical ingredient (API) or Ternidazol finished formulations upon request. The Ternidazol suppliers may include Ternidazol API manufacturers, exporters, distributors and traders.
click here to find a list of Ternidazol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ternidazol written confirmation (Ternidazol WC) is an official document issued by a regulatory agency to a Ternidazol manufacturer, verifying that the manufacturing facility of a Ternidazol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ternidazol APIs or Ternidazol finished pharmaceutical products to another nation, regulatory agencies frequently require a Ternidazol WC (written confirmation) as part of the regulatory process.
click here to find a list of Ternidazol suppliers with Written Confirmation (WC) on PharmaCompass.
Ternidazol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ternidazol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ternidazol GMP manufacturer or Ternidazol GMP API supplier for your needs.
A Ternidazol CoA (Certificate of Analysis) is a formal document that attests to Ternidazol's compliance with Ternidazol specifications and serves as a tool for batch-level quality control.
Ternidazol CoA mostly includes findings from lab analyses of a specific batch. For each Ternidazol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ternidazol may be tested according to a variety of international standards, such as European Pharmacopoeia (Ternidazol EP), Ternidazol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ternidazol USP).